SCYNEXIS, Inc. (SCYX)
NASDAQ: SCYX · Real-Time Price · USD
1.310
-0.010 (-0.76%)
Dec 3, 2024, 1:49 PM EST - Market open

SCYNEXIS Revenue

SCYNEXIS had revenue of $660.00K in the quarter ending September 30, 2024, a decrease of -62.52%. This brings the company's revenue in the last twelve months to $8.57M, down -93.70% year-over-year. In the year 2023, SCYNEXIS had annual revenue of $140.14M with 2,652.72% growth.

Revenue (ttm)
$8.57M
Revenue Growth
-93.70%
P/S Ratio
7.45
Revenue / Employee
$295,379
Employees
29
Market Cap
49.71M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023140.14M135.05M2,652.72%
Dec 31, 20225.09M-8.07M-61.32%
Dec 31, 202113.16M--
Dec 31, 2020---
Dec 31, 2019121.00K-136.00K-52.92%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CareCloud 111.01M
LakeShore Biopharma 79.42M
Cytosorbents 37.74M
Shattuck Labs 6.44M
Dyadic International 3.36M
Nutriband 1.80M
vTv Therapeutics 1.00M
CollPlant Biotechnologies 650.00K
Revenue Rankings